DNA And Gene Chip Global Market Demand Analysis, Manufacturers Share, Regions, Risk Analysis, Driving Forces and Application, Forecast To 2033 | PerkinElmer Inc., Illumina Inc., Macrogen Inc., GE Healthcare, Genisphere LLC

"The new report published by The Business Research Company, titled ""DNA And Gene Chip Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the dna and gene chip market size has grown rapidly in recent years. It will grow from $7.38 billion in 2023 to $8.4 billion in 2024 at a compound annual growth rate (CAGR) of 13.9%. The dna and gene chip market size is expected to see rapid growth in the next few years. It will grow to $13.7 billion in 2028 at a compound annual growth rate (CAGR) of 13.0%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=8205&type=smp

Early Cancer Detection Driving Growth Indna And Gene Chip Market
The rising demand for early cancer detection is significantly contributing to the growth of the DNA and gene market. Cancer is a broad class of conditions that can develop in practically any organ or tissue of the body when aberrant cells multiply uncontrollably, cross normal cell boundaries to invade nearby organs, and spread to other regions of the body. DNA and gene chips are used to measure gene expression patterns, determine the genetic and epigenetic landscape, and measure genomic regulatory elements bound by cancer transcription factors in cancerous cells. For instance, in 2022, according to the American Cancer Society, a US-based community-based, voluntary health organization, it is projected that there will be approximately 1.9 million newly diagnosed cancer cases and 609,360 deaths from cancer in the United States. Therefore, rising demand for early cancer detection is driving the growth of the DNA and gene chip market.

Strategic Partnerships And Collaborations Fuel Growth In Dna And Gene Chip Market
Strategic partnerships and collaborations are the key trends gaining popularity in the DNA and gene chip market. Many companies operating in this sector looking for partnerships to strengthen their position in the DNA and gene chip market. For instance, in June 2022, Avesthagen Limited, an India-based integrated systems biology platform company, entered into a four-year strategic partnership with Wipro Limited, an India-based information technology company. Through this partnership, both companies execute the project titled ""Cancer Risk Assessed by NGS profiling of circulating free DNA and RNA for lung cancer project-related genomics sequencing services. Further, in May 2022, Thermo Fisher Scientific, a US-based supplier of analytical instruments, partnered with Qatar Genome Program (QGP), a member of Qatar Foundation (QF)to develop an Axiom custom genotyping array for pan-Arab populations, utilizing whole genome sequencing data from 19 Arab countries. The array, with 800,000 variants, aims to enhance genomic research, focusing on conditions such as diabetes, cardiovascular diseases, autism, and cancer. The collaboration supports Qatar's national vision for improved population health and the advancement of precision medicine for people of Arab identity worldwide. Thermo Fisher's Axiom microarray technology facilitates accelerated precision medicine initiatives.

The dna and gene chip market covered in this report is segmented -
1) By Type: Oligonucleotide DNA (o-DNA), Complementary DNA (c-DNA), Other Types
2) By Application: Cancer Diagnostics, Gene Expression, Proteomics, Genomics, Drug Discovery, Agrigenomics, Other Applications
3) By End User: Academic And Government Research Institutes, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostics Centers, Other End Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=8205&type=discount

Major companies operating in the dna and gene chip market report are PerkinElmer Inc., Illumina Inc., Thermo Fisher Scientific Inc., Macrogen Inc., Agilent Technologies Inc., Greiner Bio-One International GmbH, CapitalBio Corporation, Microarrays Inc., bioMérieux SA, Applied Microarrays Inc., Biometrix Technology Inc., Oxford Gene Technology IP Limited, Affymetrix Inc., Bioneer Corporation, Eurofins MWG Operon LLC, F. Hoffmann-La Roche Ltd, QIAGEN N.V., Bio-Rad Laboratories Inc., Arrayit Corporation, BioChain Institute Inc., Cepheid, Clontech Laboratories Inc., Eppendorf AG, Fluidigm Corporation, GE Healthcare, Genisphere LLC, Gyros Protein Technologies AB, Hitachi High-Technologies Corporation, LC Sciences, Luminex Corporation

Contents of the report:
1. Executive Summary
2. DNA And Gene Chip Market Report Structure
3. DNA And Gene Chip Market Trends And Strategies
4. DNA And Gene Chip Market - Macro Economic Scenario
5. DNA And Gene Chip Market Size And Growth
…..
27. DNA And Gene Chip Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/dna-and-gene-chip-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.